ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 570,20
-0,77%
Dow Jones
38 834,86
0,15%
DAX
18 067,91
-0,31%
Brent Oil
84,695
-0,11%
Bitcoin
64 841,63
-0,46%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) Actualités

GSK GSK plc

40,83
0,17 (0,42%)
19 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
GSK plc GSK NYSE Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,17 0,42% 40,83 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
41,03 40,785 41,08 40,95 40,66
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/6/202400:57BWUS FDA Approves Expanded Age Indication for GSK’s AREXVY,..
03/6/202414:10BWJemperli (dostarlimab-gxly) trial continues to show..
02/6/202416:56BWBelantamab Mafodotin combination reduced the risk of disease..
24/5/202412:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/5/202413:18IHMARKETNEWSCalPERS to Oppose Exxon Mobil Directors; Microsoft Unveils..
21/5/202412:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/5/202416:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/5/202413:36IHMARKETNEWSOpenAI’s Reddit Partnership Boosts Shares by 14%, Microsoft..
17/5/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/5/202416:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/5/202407:00GLOBEBioVersys Announces Expansion of Strategic Collaboration..
26/4/202413:48IHMARKETNEWSAnglo American Rejects BHP Group’s Offer, Toyota Invests..
16/3/202413:00BWPositive RUBY phase III data show potential for Jemperli..
08/3/202418:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/3/202418:00BWGSK Doubles COiMMUNITY Grant Funding, Launches Patient..
07/3/202412:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/3/202417:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/3/202419:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/3/202418:30EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
05/3/202418:10EDGAR2Form 20-F - Annual and transition report of foreign private..
05/3/202412:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202416:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202415:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202412:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202412:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202412:11IHMARKETNEWSShares of WW International Plummet after Oprah Exits, EA..
26/2/202416:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/2/202412:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/2/202416:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202412:34IHMARKETNEWSCisco Systems Stock Drops 5% Following Restructuring Plan,..
08/2/202413:00GLOBEAlector Announces First Patient Dosed in PROGRESS-AD Phase 2..
07/2/202422:01GLOBE23andMe Reports Third Quarter Fiscal 2024 Financial Results
07/2/202413:00GLOBEFDA Grants Latozinemab Breakthrough Therapy Designation for..
06/2/202413:00BWGSK’s RSV Vaccine, AREXVY, Accepted Under Priority Review in..
01/2/202412:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202419:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202412:28IHMARKETNEWSWalmart’s Stock Split, Elon Musk’s Billion-Dollar Package..
30/1/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202412:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/1/202412:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202420:11BWElegen e GSK firmano un accordo di collaborazione e di..
24/1/202418:52BWElegen und GSK unterzeichnen Kooperations- und..
24/1/202417:37BWElegen et GSK signent un accord de collaboration et de..
24/1/202414:00BWElegen and GSK Sign Collaboration and Licensing Agreement to..
19/1/202422:20EDGAR2Form SC 13D/A - General statement of acquisition of..
19/1/202417:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/1/202413:49DJNHilleVax Taps Sean McLoughlin as Chief Operating Officer
17/1/202418:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202416:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202414:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Dernières Valeurs Consultées

NYSE
GSK
GSK
BIT
S15541
Societe Generale
ASX
NRZO
NeuRizer
LSE
35UC
Sthn.pac.fin4as
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés